Stifel Financial Corp Increases Stock Holdings in Avantor, Inc. (NYSE:AVTR)

Stifel Financial Corp boosted its position in shares of Avantor, Inc. (NYSE:AVTR) by 27.5% in the 3rd quarter, Holdings Channel.com reports. The fund owned 50,848 shares of the company’s stock after purchasing an additional 10,980 shares during the period. Stifel Financial Corp’s holdings in Avantor were worth $1,315,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Blue Trust Inc. increased its holdings in shares of Avantor by 1,830.3% in the second quarter. Blue Trust Inc. now owns 1,467 shares of the company’s stock worth $31,000 after purchasing an additional 1,391 shares during the period. Bank of New York Mellon Corp raised its stake in shares of Avantor by 1.6% during the second quarter. Bank of New York Mellon Corp now owns 2,325,329 shares of the company’s stock worth $49,297,000 after acquiring an additional 35,497 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its holdings in shares of Avantor by 35.1% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 1,157,855 shares of the company’s stock worth $24,547,000 after acquiring an additional 300,579 shares during the last quarter. Cambridge Investment Research Advisors Inc. purchased a new stake in shares of Avantor in the 2nd quarter valued at $2,353,000. Finally, Kintegral Advisory LLC bought a new position in shares of Avantor during the 2nd quarter valued at $514,000. Institutional investors own 95.08% of the company’s stock.

Analyst Ratings Changes

AVTR has been the subject of several analyst reports. Robert W. Baird cut their price target on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research report on Monday, October 28th. Royal Bank of Canada restated an “outperform” rating and set a $34.00 price target on shares of Avantor in a research report on Thursday, September 26th. Wells Fargo & Company lowered their price objective on Avantor from $30.00 to $28.00 and set an “overweight” rating for the company in a research report on Monday, October 28th. UBS Group cut their target price on shares of Avantor from $30.00 to $29.00 and set a “buy” rating on the stock in a report on Tuesday, October 8th. Finally, Barclays cut their price objective on Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a research report on Friday, October 25th. Two equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. According to data from MarketBeat.com, Avantor has a consensus rating of “Moderate Buy” and a consensus price target of $27.69.

Avantor Stock Performance

NYSE:AVTR opened at $21.21 on Friday. The stock’s 50 day simple moving average is $22.15 and its two-hundred day simple moving average is $23.44. Avantor, Inc. has a 1 year low of $19.59 and a 1 year high of $28.00. The company has a market cap of $14.44 billion, a price-to-earnings ratio of 46.11, a PEG ratio of 2.75 and a beta of 1.29. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.54 and a quick ratio of 1.06.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.